Copyright
©The Author(s) 2020.
World J Gastrointest Surg. Jan 27, 2020; 12(1): 17-27
Published online Jan 27, 2020. doi: 10.4240/wjgs.v12.i1.17
Published online Jan 27, 2020. doi: 10.4240/wjgs.v12.i1.17
Figure 1 Comparison of recurrence-free survival curves between groups.
Patients in group III have significant inferior survival curves compared with the other two groups. The 5-year recurrence-free survival rate was 54.7% (P < 0.0005).
- Citation: Wu TH, Wang YC, Cheng CH, Lee CF, Wu TJ, Chou HS, Chan KM, Lee WC. Outcomes associated with the intention of loco-regional therapy prior to living donor liver transplantation for hepatocellular carcinoma. World J Gastrointest Surg 2020; 12(1): 17-27
- URL: https://www.wjgnet.com/1948-9366/full/v12/i1/17.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v12.i1.17